Marketing & Sales

Magazine articles on marketing, advertising, and sales.

Old Articles: <Older 3691-3700 Newer>

CRM June 2014 Maria Minsker	Finding the Soft Edge Solid strategy and great execution are just two sides of the long-term success triangle.
Registered Rep. May 19, 2014 Anne Field	Breathing New Life Into an Old Marketing Strategy Often, advisors can take a while before they understand the importance of using social media to solidify their reputation, at the least, and, at best, to attract real business.
Registered Rep. May 8, 2014 Matt Oechsli	Working the Room As much as we tout financial advice as a relationship business, many advisors struggle with networking. Instead, they make it all about business.
CRM May 16, 2014 Woody Driggs	Six Takeaways for Marketing Executives Building a differentiated customer experience is a baseline requirement of success.
CRM May 9, 2014 James & Montaudo	CRM + Customer Service = Long-Term Results Here are four steps for improving the front-line retail experience through back-end data. Keep in mind that individuals remember positive interactions far more than they do transactions.
Fast Company June 2014 Julie Makinen	Adam Schokora, Jimi Zhang, Leon Yan, and Taylor Shen NeochaEdge is a hub of Chinese creativity and commerce that's got global brands banging at the door. A nimble group of whiz kids is marketing the talents of young Chinese artists and generating content for multinational companies.
Pharmaceutical Executive May 6, 2014 Ben Comer	The Brands of Yesteryear: Where Are They Now? We check back with previous Pharm Exec Brand of the Year winners like Januvia, Abbvie, and Gilenya to see how things are going.
Pharmaceutical Executive May 1, 2014 Ben Comer	2014 Brand of the Year Brand of the Year recipients for 2014 are Copaxone, a mainstay treatment for multiple sclerosis, and KORLYM for diseases driven by excess production of the metabolic hormone, cortisol. We profile the journey of both drugs.
Pharmaceutical Executive May 1, 2014 Nadeem Rehmat	Gravity Shift: Timely Lessons For Big Pharma MNCs can learn a lot from generic companies in their strategic approaches to emerging markets.
Fast Company Alice Truong	Inside The Billion-Dollar Play To Bring Japanese Cool To The World The Cool Japan Fund launched last year with 57.5 billion yen ($560 million dollars), the vast majority of that financed by the government. In total, the fund will spend about $1 billion to stimulate cultural exports.
<Older 3691-3700 Newer> Return to current articles.